1. Home
  2. SNOA vs AMBO Comparison

SNOA vs AMBO Comparison

Compare SNOA & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNOA
  • AMBO
  • Stock Information
  • Founded
  • SNOA 1999
  • AMBO 2000
  • Country
  • SNOA United States
  • AMBO United States
  • Employees
  • SNOA N/A
  • AMBO 163
  • Industry
  • SNOA Biotechnology: Pharmaceutical Preparations
  • AMBO Other Consumer Services
  • Sector
  • SNOA Health Care
  • AMBO Real Estate
  • Exchange
  • SNOA Nasdaq
  • AMBO Nasdaq
  • Market Cap
  • SNOA 6.4M
  • AMBO 7.0M
  • IPO Year
  • SNOA 2007
  • AMBO 2010
  • Fundamental
  • Price
  • SNOA $3.61
  • AMBO $2.95
  • Analyst Decision
  • SNOA
  • AMBO
  • Analyst Count
  • SNOA 0
  • AMBO 0
  • Target Price
  • SNOA N/A
  • AMBO N/A
  • AVG Volume (30 Days)
  • SNOA 74.2K
  • AMBO 10.7K
  • Earning Date
  • SNOA 08-07-2025
  • AMBO 01-01-0001
  • Dividend Yield
  • SNOA N/A
  • AMBO N/A
  • EPS Growth
  • SNOA N/A
  • AMBO N/A
  • EPS
  • SNOA N/A
  • AMBO 0.11
  • Revenue
  • SNOA $14,288,000.00
  • AMBO $9,392,000.00
  • Revenue This Year
  • SNOA $38.54
  • AMBO N/A
  • Revenue Next Year
  • SNOA N/A
  • AMBO N/A
  • P/E Ratio
  • SNOA N/A
  • AMBO $27.78
  • Revenue Growth
  • SNOA 12.20
  • AMBO 2.50
  • 52 Week Low
  • SNOA $1.75
  • AMBO $1.00
  • 52 Week High
  • SNOA $9.37
  • AMBO $5.55
  • Technical
  • Relative Strength Index (RSI)
  • SNOA 62.41
  • AMBO 60.08
  • Support Level
  • SNOA $2.97
  • AMBO $2.25
  • Resistance Level
  • SNOA $3.04
  • AMBO $2.70
  • Average True Range (ATR)
  • SNOA 0.23
  • AMBO 0.29
  • MACD
  • SNOA 0.09
  • AMBO 0.08
  • Stochastic Oscillator
  • SNOA 59.71
  • AMBO 72.97

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

Share on Social Networks: